Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GlcNAc in NGLY1-CDDG
NCT05402345Phase 2Active, not recruiting
- Start
- Jan 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of n-acetyl-d-glucosamine in NGLY1 Deficiency (NGLY1D). Started Jan 2025; status: active, not recruiting.
02
Drugs
n-acetyl-d-glucosamine
03
Conditions
NGLY1 Deficiency (NGLY1D)
Beyond the preview
Go deeper on NCT05402345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05402345.